Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Andrews

Showing results (41-50 of 210) with videos related to

Pageof 21
Sort By:
Breast Cancer Research and Treatment|November 13, 2008
Tamoxifen and ICI 182,780 increase Bcl-2 levels and inhibit growth of breast carcinoma cells by modulating PI3K/AKT, ERK and IGF-1R pathways independent of ERalphaLe Lam, Xiuying Hu, Zackie Aktary, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2016
Using Förster-Resonance Energy Transfer to Measure Protein Interactions Between Bcl-2 Family Proteins on Mitochondrial MembranesJustin P Pogmore, James M Pemberton, Xiaoke Chi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
Glioblastoma patients exhibit circulating tumor-specific CD8+ T cellsJie Tang, Phyllis Flomenberg, Larry Harshyne, et al.
Journal of Cell Science|March 1, 2012
Multiple post-translational modifications regulate E-cadherin transport during apoptosisFei Geng, Weijia Zhu, Richard A Anderson, et al.
BMC Cancer|August 25, 2006
Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell lineAline A Fiebig, Weijia Zhu, Catherine Hollerbach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2015
Molecular Pathways: Leveraging the BCL-2 Interactome to Kill Cancer Cells--Mitochondrial Outer Membrane Permeabilization and BeyondHetal Brahmbhatt, Sina Oppermann, Elizabeth J Osterlund, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2007
Development of dimeric modulators for anti-apoptotic Bcl-2 proteinsLiangyou Wang, Fansen Kong, Candis L Kokoski, et al.
Plos One|November 29, 2018
Peak emission wavelength and fluorescence lifetime are coupled in far-red, GFP-like fluorescent proteinsLaura Canty, Santosh Hariharan, Qian Liu, et al.
Journal of Pediatric Ophthalmology and Strabismus|February 13, 2003
Optic nerve glioma in a patient with von Hippel-Lindau syndromeJeffrey A Nau, Carol L Shields, Jerry A Shields, et al.
Journal of Clinical Medicine|February 25, 2022
Challenges and Opportunities for Immunotherapeutic Intervention against Myeloid Immunosuppression in GlioblastomaMark A Exley, Samantha Garcia, Amelia Zellander, et al.
Pageof 21

Showing results (41-50 of 210) with videos related to

Sort By:
Pageof 21
Breast Cancer Research and Treatment|November 13, 2008
Tamoxifen and ICI 182,780 increase Bcl-2 levels and inhibit growth of breast carcinoma cells by modulating PI3K/AKT, ERK and IGF-1R pathways independent of ERalphaLe Lam, Xiuying Hu, Zackie Aktary, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2016
Using Förster-Resonance Energy Transfer to Measure Protein Interactions Between Bcl-2 Family Proteins on Mitochondrial MembranesJustin P Pogmore, James M Pemberton, Xiaoke Chi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
Glioblastoma patients exhibit circulating tumor-specific CD8+ T cellsJie Tang, Phyllis Flomenberg, Larry Harshyne, et al.
Journal of Cell Science|March 1, 2012
Multiple post-translational modifications regulate E-cadherin transport during apoptosisFei Geng, Weijia Zhu, Richard A Anderson, et al.
BMC Cancer|August 25, 2006
Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell lineAline A Fiebig, Weijia Zhu, Catherine Hollerbach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2015
Molecular Pathways: Leveraging the BCL-2 Interactome to Kill Cancer Cells--Mitochondrial Outer Membrane Permeabilization and BeyondHetal Brahmbhatt, Sina Oppermann, Elizabeth J Osterlund, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2007
Development of dimeric modulators for anti-apoptotic Bcl-2 proteinsLiangyou Wang, Fansen Kong, Candis L Kokoski, et al.
Plos One|November 29, 2018
Peak emission wavelength and fluorescence lifetime are coupled in far-red, GFP-like fluorescent proteinsLaura Canty, Santosh Hariharan, Qian Liu, et al.
Journal of Pediatric Ophthalmology and Strabismus|February 13, 2003
Optic nerve glioma in a patient with von Hippel-Lindau syndromeJeffrey A Nau, Carol L Shields, Jerry A Shields, et al.
Journal of Clinical Medicine|February 25, 2022
Challenges and Opportunities for Immunotherapeutic Intervention against Myeloid Immunosuppression in GlioblastomaMark A Exley, Samantha Garcia, Amelia Zellander, et al.
Pageof 21